DE69630145D1 - TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
DE69630145D1
DE69630145D1 DE69630145T DE69630145T DE69630145D1 DE 69630145 D1 DE69630145 D1 DE 69630145D1 DE 69630145 T DE69630145 T DE 69630145T DE 69630145 T DE69630145 T DE 69630145T DE 69630145 D1 DE69630145 D1 DE 69630145D1
Authority
DE
Germany
Prior art keywords
taxal
derivatives
production
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69630145T
Other languages
German (de)
Other versions
DE69630145T2 (en
Inventor
Herve Bouchard
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of DE69630145D1 publication Critical patent/DE69630145D1/en
Application granted granted Critical
Publication of DE69630145T2 publication Critical patent/DE69630145T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69630145T 1995-12-22 1996-12-19 TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Expired - Lifetime DE69630145T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9515379 1995-12-22
FR9515379A FR2742751B1 (en) 1995-12-22 1995-12-22 NOVEL TAXOIDS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1996/002031 WO1997023473A1 (en) 1995-12-22 1996-12-19 Novel taxoids, preparation thereof and pharmaceutical compositions containing same

Publications (2)

Publication Number Publication Date
DE69630145D1 true DE69630145D1 (en) 2003-10-30
DE69630145T2 DE69630145T2 (en) 2004-07-15

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630145T Expired - Lifetime DE69630145T2 (en) 1995-12-22 1996-12-19 TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (41)

Country Link
US (1) US5728849A (en)
EP (1) EP0876362B1 (en)
JP (1) JP3953106B2 (en)
KR (1) KR100500351B1 (en)
CN (1) CN1103766C (en)
AR (1) AR005197A1 (en)
AT (1) ATE250593T1 (en)
AU (1) AU712597B2 (en)
BG (1) BG63204B1 (en)
BR (1) BR9612135A (en)
CA (1) CA2238884C (en)
CO (1) CO4520184A1 (en)
CZ (1) CZ294972B6 (en)
DE (1) DE69630145T2 (en)
DK (1) DK0876362T3 (en)
DZ (1) DZ2149A1 (en)
EA (1) EA001533B1 (en)
ES (1) ES2202490T3 (en)
FR (1) FR2742751B1 (en)
HK (1) HK1017895A1 (en)
HU (1) HU225032B1 (en)
IL (1) IL124994A (en)
IN (4) IN186768B (en)
MA (1) MA26412A1 (en)
MX (1) MX9804688A (en)
MY (1) MY113934A (en)
NO (1) NO317358B1 (en)
NZ (1) NZ324337A (en)
OA (1) OA10700A (en)
PE (1) PE25198A1 (en)
PL (1) PL189311B1 (en)
PT (1) PT876362E (en)
RO (1) RO116194B1 (en)
SK (1) SK282835B6 (en)
TN (1) TNSN96169A1 (en)
TR (1) TR199801179T2 (en)
TW (1) TW371659B (en)
UA (1) UA48205C2 (en)
UY (1) UY24386A1 (en)
WO (1) WO1997023473A1 (en)
ZA (1) ZA9610737B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
SK13632001A3 (en) 2000-02-02 2002-06-04 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
ES2282386T3 (en) * 2001-02-24 2007-10-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG DERIVATIVES OF XANTINA, ITS PREPARATION AND ITS USE AS MEDICATIONS.
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (en) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
EP1669358A1 (en) 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (en) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals
CN103951667A (en) 2006-05-04 2014-07-30 勃林格殷格翰国际有限公司 Polymorphs
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (en) 2006-05-04 2008-04-25 Boehringer Ingelheim Int USES OF DPP IV INHIBITORS
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
EP3542801A1 (en) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
AR071175A1 (en) 2008-04-03 2010-06-02 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INHIBITOR OF DIPEPTIDIL-PEPTIDASA-4 (DPP4) AND A COMPARING PHARMACO
PE20100156A1 (en) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int NAFLD TREATMENT
UY32030A (en) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
BRPI0916997A2 (en) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh DPP-4 INHIBITOR AND ITS USE
PE20110297A1 (en) * 2008-08-15 2011-05-26 Boehringer Ingelheim Int DPP-4 INHIBITORS FOR WOUND HEALING
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
US8865729B2 (en) 2008-12-23 2014-10-21 Boehringer Ingelheim International Gmbh Salt forms of a xanthine compound
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
AU2010323068B2 (en) 2009-11-27 2015-09-03 Boehringer Ingelheim International Gmbh Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
EA033415B1 (en) 2010-05-05 2019-10-31 Boehringer Ingelheim Int Methods for treating obesity, use of dpp-4 inhibitor in these methods and method for treating patients suffering from type 2 diabetes mellitus
BR112012032579B1 (en) 2010-06-24 2021-05-11 Boehringer Ingelheim International Gmbh use of linagliptin and pharmaceutical composition comprising linagliptin and long-acting basal insulin
AR083878A1 (en) 2010-11-15 2013-03-27 Boehringer Ingelheim Int VASOPROTECTORA AND CARDIOPROTECTORA ANTIDIABETIC THERAPY, LINAGLIPTINA, TREATMENT METHOD
NZ618698A (en) 2011-07-15 2015-08-28 Boehringer Ingelheim Int Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (en) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Xanthine derivatives as DPP-4 inhibitors for the treatment of glomerular epithelial cell related disorders and / or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CN105849086B (en) 2012-11-24 2018-07-31 杭州多禧生物科技有限公司 Hydrophily chain junctor and its application on drug molecule and cell-binding molecules conjugation reaction
FR3010839B1 (en) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas DEVICE FOR ELECTRICALLY CONNECTING AT LEAST ONE CONDUCTOR IN A TERMINAL BELONGING TO AN ELECTRICAL APPARATUS
CN106414465B (en) 2014-02-28 2021-11-16 杭州多禧生物科技有限公司 Charged linkers and their use in conjugation reactions
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
EP3319936A4 (en) 2015-07-12 2019-02-06 Suzhou M-conj Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
MX2018015089A (en) 2016-06-10 2019-05-13 Boehringer Ingelheim Int Combinations of linagliptin and metformin.
KR20220150408A (en) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (en) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Method of synthesis of taxol derivatives
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (en) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa PROCESS FOR THE PREPARATION OF DERIVATIVES OF BACCATIN III AND DESACETYL-10 BACCATIN III.
RU2059631C1 (en) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Derivatives of taxol and pharmaceutical composition showing antitumor activity
ATE181551T1 (en) * 1992-04-17 1999-07-15 Abbott Lab TAXOL DERIVATIVES
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
HUP9904046A3 (en) 2001-08-28
JP3953106B2 (en) 2007-08-08
IN188469B (en) 2002-09-28
US5728849A (en) 1998-03-17
KR100500351B1 (en) 2005-12-21
ZA9610737B (en) 1997-06-27
CN1205697A (en) 1999-01-20
EP0876362A1 (en) 1998-11-11
DK0876362T3 (en) 2004-02-02
IN188470B (en) 2002-09-28
TNSN96169A1 (en) 2005-03-15
SK282835B6 (en) 2002-12-03
NO982580L (en) 1998-06-05
IN186768B (en) 2001-11-03
TR199801179T2 (en) 1998-10-21
AU712597B2 (en) 1999-11-11
HU225032B1 (en) 2006-05-29
AU1180997A (en) 1997-07-17
MA26412A1 (en) 2004-12-20
MX9804688A (en) 1998-10-31
PL189311B1 (en) 2005-07-29
CA2238884C (en) 2007-02-06
MY113934A (en) 2002-06-29
UY24386A1 (en) 2001-08-27
ATE250593T1 (en) 2003-10-15
JP2000502671A (en) 2000-03-07
SK85398A3 (en) 1998-11-04
EA199800588A1 (en) 1998-12-24
EP0876362B1 (en) 2003-09-24
CZ196198A3 (en) 1998-09-16
DE69630145T2 (en) 2004-07-15
NZ324337A (en) 2000-03-27
BG63204B1 (en) 2001-06-29
OA10700A (en) 2002-11-27
WO1997023473A1 (en) 1997-07-03
PL327405A1 (en) 1998-12-07
FR2742751A1 (en) 1997-06-27
AR005197A1 (en) 1999-04-14
TW371659B (en) 1999-10-11
CN1103766C (en) 2003-03-26
KR19990076680A (en) 1999-10-15
HK1017895A1 (en) 1999-12-03
IN188680B (en) 2002-10-26
BR9612135A (en) 1999-07-13
CZ294972B6 (en) 2005-04-13
CO4520184A1 (en) 1997-10-15
PT876362E (en) 2004-02-27
BG102569A (en) 1999-04-30
DZ2149A1 (en) 2002-10-23
EA001533B1 (en) 2001-04-23
NO317358B1 (en) 2004-10-18
NO982580D0 (en) 1998-06-05
RO116194B1 (en) 2000-11-30
IL124994A (en) 2000-12-06
CA2238884A1 (en) 1997-07-03
ES2202490T3 (en) 2004-04-01
UA48205C2 (en) 2002-08-15
IL124994A0 (en) 1999-01-26
HUP9904046A1 (en) 2001-04-28
FR2742751B1 (en) 1998-01-30
PE25198A1 (en) 1998-05-10

Similar Documents

Publication Publication Date Title
DE69630145D1 (en) TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE188471T1 (en) TAXAL DERIVATIVES, THEIR PRODUCTION AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
ATE478840T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 3-AMINOAZETIDEDINE DERIVATIVES, THESE DERIVATIVES AND THE PRODUCTION THEREOF
ATE164843T1 (en) NAPHTHALINE DERIVATIVES, THEIR PRODUCTION PROCESSES AND INTERMEDIATE PRODUCTS THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE239703T1 (en) AZETIDINE DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM
DE69806831D1 (en) Dithiolan derivatives, their production and their healing effect
DE60001546D1 (en) LIPONIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE187167T1 (en) AMIDO-3-PYRAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE193533T1 (en) TAXAL DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69928260D1 (en) SULFUR-SUBSTITUTED SULFONYLAMINOCARBOXYLIC ACID N-ARYLAMIDES, THEIR PREPARATION, THEIR USE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE59907961D1 (en) INDENO-, NAPHTHO- AND BENZOCYCLOHEPTA-DIHYDROTHIAZOL DERIVATIVES, THEIR PRODUCTION AND USE THEREOF AS ANOREECTIC MEDICINAL PRODUCTS
ATE297935T1 (en) 2-(IMINOMETHYL)AMINOPHENYL DERIVATIVES, THEIR PREPARATION, USE AS MEDICATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
DE69815094D1 (en) 2- (IMINOETHYL) -AMINOPHENYL DERIVATIVES, THEIR PRODUCTION, THE USE THEREOF AS MEDICAMENTS AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ATE222897T1 (en) SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69610085T2 (en) TAXOL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE204266T1 (en) TAXOIDS, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE515995T1 (en) N- (5-THIOXO-L-PROPYL) -L-CYSTEIN AND DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS.
DE69520870T2 (en) Esculetin derivatives, process for their preparation and pharmaceutical composition
DE3578597D1 (en) 4-PHENYLPHTHALAZINE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO975680D0 (en) Oral pharmaceutical preparation of piperidinoalkanol compounds in solution form
BR9607433A (en) Pharmaceutical composition for parental administration
DE69622648D1 (en) BENZOXALEPINE DERIVATIVES, THEIR SALTS AND MEDICINAL PRODUCTS CONTAINING THEM
DE69614568D1 (en) NEW TAXOIDS, PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69509621D1 (en) Diarylheptanoid derivative and pharmaceutical composition containing the same
IT1257000B (en) ANTI-COLINESTERASIC ESEROLINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CHELI CONTAIN.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC